These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6998556)

  • 1. 5-Fluorouracil, methyl-CCNU, and radiotherapy with or without testolactone for localized adenocarcinoma of the exocrine pancreas: a Southwest Oncology Group Study.
    McCracken JD; Ray P; Heilbrun LK; Vaitkevicius VK; Saiki JH; Rivkin SE; Rossof AH; Moore TN
    Cancer; 1980 Oct; 46(7):1518-22. PubMed ID: 6998556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Costanzi J; Bottomley R; King GW; Bonnet J; Thigpen T; Whitecar J; Haas C; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Oct; 44(4):1215-21. PubMed ID: 387204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-drug chemotherapy with and without radiation for carcinoma of the stomach and pancreas: a prospective randomized trial.
    Hazel JJ; Thirlwell MP; Huggins M; Maksymiuk A; MacFarlane JK
    J Can Assoc Radiol; 1981 Sep; 32(3):164-5. PubMed ID: 7028759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
    Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
    Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
    Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
    Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
    Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
    Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
    J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer.
    Lacave A; Wils J; Bleiberg H; Diaz-Rubio E; Duez N; Dalesio O
    J Clin Oncol; 1987 Sep; 5(9):1387-93. PubMed ID: 3305795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study.
    Buroker T; Kim PN; Groppe C; McCracken J; O'Bryan R; Panettiere F; Coltman C; Bottomley R; Wilson H; Bonnet J; Thigpen T; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1978 Sep; 42(3):1228-33. PubMed ID: 359121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
    Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
    Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments.
    Taylor SG; DeWys WD; Perlia CP; Wolter J; Slayton RE; Kosova LA; Khandekar JD
    Cancer; 1979 Sep; 44(3):824-30. PubMed ID: 383272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report.
    Higgins GA; Amadeo JH; Smith DE; Humphrey EW; Keehn RJ
    Cancer; 1983 Sep; 52(6):1105-12. PubMed ID: 6349780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized study of 5-FU and CCNU in pancreatic cancer: report of the Veterans Administration Surgical Adjuvant Cancer Chemotherapy Study Group.
    Frey C; Twomey P; Keehn R; Elliott D; Higgins G
    Cancer; 1981 Jan; 47(1):27-31. PubMed ID: 7006790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones".
    Moertel CG; Engstrom P; Lavin PT; Gelber RD; Carbone PP
    Surgery; 1979 May; 85(5):509-13. PubMed ID: 155322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with 5-fluorouracil and methyl-CCNU for the treatment of advanced gastrointestinal cancer.
    Brutti A; Liberati AM; Biscottini B; Fatati G; Sini S; Barzi AM; Grignani F
    Tumori; 1979 Jun; 65(3):339-44. PubMed ID: 462584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.